Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
CFD
U.S. stock CFD derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
IPO Access
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
Sanofi appoints Belen Garilho as CEO in a major leadership overhaul
Investing.com - Sanofi (EPA:SASY) announced on Thursday that Belén Garijo will become the company's new CEO, succeeding Paul Hudson, whose board term will not be renewed.
According to the decision made at the Sanofi Board of Directors meeting on February 11, Hudson's last day as CEO will be February 17, 2026. Executive Vice President Olivier Charmeil will serve as interim CEO during the transition and has been a member of the Executive Committee since 2011.
Garijo will officially assume her duties after the Sanofi Annual General Meeting on April 29, 2026. The board will also propose her as a director candidate to shareholders at this meeting.
Garijo is currently CEO of Merck KGaA, a position she has held since 2021, making her the first female leader among Germany's DAX40 companies. She previously worked at Sanofi for 15 years, serving as Vice President of European and Canadian pharmaceutical operations and being a member of the Executive Committee.
Unlocking InvestingPro insights on chip manufacturers and advanced AI analysis
The company stated that Garijo will focus on implementing Sanofi’s strategy more rigorously and accelerating preparations for the group's future. Her priorities will include enhancing productivity, governance, and R&D innovation capabilities.
Chairman Frédéric Oudéa thanked Hudson for his work and strategic initiatives during his tenure. He described Garijo as "a highly respected leader in our industry with an undisputed reputation," and noted that she has the experience and qualifications to "accelerate the pace, strengthen the quality of strategic execution, and lead the company through its next growth cycle."
The appointment of Garijo as director, as well as a proposal to amend the company bylaws to increase the age limit for CEO appointments, will be submitted for shareholder approval at the April 29 meeting.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.